Scholarlink

Background <p>Hirschsprung disease (HD) is a congenital intestinal neuropathy characterised by distal colonic aganglionosis. While laparoscopic-assisted pull-through (LAPT) has gained widespread adoption, existing evidence is limited by study heterogeneity, retrospective designs, and non-standardised outcome definitions. This study aimed to systematically evaluate the safety profile, complications, and functional outcomes following LAPT for HD.</p> Methods <p>We searched PubMed, Scopus, Cochrane Library, and Web of Science through May 2025, adhering to PRISMA 2020 standards. We included studies that enrolled ≥ 10 patients undergoing LAPT and had ≥ 6-month follow-up. Pooled proportions were calculated via Freeman–Tukey double-arcsine transformation with DerSimonian–Laird random-effects models. Study quality was appraised using a modified NIH tool.</p> Results <p>Thirty-three studies (2,415 patients) met the inclusion criteria. The pooled conversion rate was 1% (95% CI: 0–2%), the mean operative time was 150&#xa0;min (95% CI: 135–166), and the intraoperative complication rate was 5% (95% CI: 2–9%). Anastomotic leak occurred in 2% (95% CI: 1–3%; I² = 0%). HAEC developed early in 9% (95% CI: 6–13%; I² = 83.5%) and late in 11% (95% CI: 8–15%; I² = 66.4%). Faecal incontinence occurred in 9% (95% CI: 5–16%) and constipation in 8% (95% CI: 5–11%). The reoperation rate was 4% (95% CI: 2–7%), and the mortality rate was 1% (95% CI: 1–2%; I² = 0%). Technique-specific subgroup analyses showed no significant differences for most outcomes.</p> Conclusion <p>LAPT for HD demonstrates excellent perioperative safety with low mortality and conversion rates. However, persistent HAEC and functional complications remain concerning. Pooled estimates for outcomes with high heterogeneity (I² &gt; 75%) should be interpreted as descriptive summaries. Standardised outcome definitions, validated functional assessment tools, and high-quality comparative trials are needed to optimise technique selection.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Surgical outcomes of laparoscopic-assisted pull-through operations for Hirschsprung disease: a systematic review and meta-analysis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月16日

查看全文
  • Amany Elsayed Eissa,
  • Noureldin Abdelrhman Ahmed,
  • Mohammad Alsayed Daboos,
  • Ahmed Abdelmohsen

摘要

Background

Hirschsprung disease (HD) is a congenital intestinal neuropathy characterised by distal colonic aganglionosis. While laparoscopic-assisted pull-through (LAPT) has gained widespread adoption, existing evidence is limited by study heterogeneity, retrospective designs, and non-standardised outcome definitions. This study aimed to systematically evaluate the safety profile, complications, and functional outcomes following LAPT for HD.

Methods

We searched PubMed, Scopus, Cochrane Library, and Web of Science through May 2025, adhering to PRISMA 2020 standards. We included studies that enrolled ≥ 10 patients undergoing LAPT and had ≥ 6-month follow-up. Pooled proportions were calculated via Freeman–Tukey double-arcsine transformation with DerSimonian–Laird random-effects models. Study quality was appraised using a modified NIH tool.

Results

Thirty-three studies (2,415 patients) met the inclusion criteria. The pooled conversion rate was 1% (95% CI: 0–2%), the mean operative time was 150 min (95% CI: 135–166), and the intraoperative complication rate was 5% (95% CI: 2–9%). Anastomotic leak occurred in 2% (95% CI: 1–3%; I² = 0%). HAEC developed early in 9% (95% CI: 6–13%; I² = 83.5%) and late in 11% (95% CI: 8–15%; I² = 66.4%). Faecal incontinence occurred in 9% (95% CI: 5–16%) and constipation in 8% (95% CI: 5–11%). The reoperation rate was 4% (95% CI: 2–7%), and the mortality rate was 1% (95% CI: 1–2%; I² = 0%). Technique-specific subgroup analyses showed no significant differences for most outcomes.

Conclusion

LAPT for HD demonstrates excellent perioperative safety with low mortality and conversion rates. However, persistent HAEC and functional complications remain concerning. Pooled estimates for outcomes with high heterogeneity (I² > 75%) should be interpreted as descriptive summaries. Standardised outcome definitions, validated functional assessment tools, and high-quality comparative trials are needed to optimise technique selection.